MRI derived brain atrophy in PSP and MSA-P: Determining sample size to detect treatment effects

Author： Paviour Dominic Price Shona Lees Andrew Fox Nick

ISSN： 0340-5354

Source： Journal of Neurology, Vol.254, Iss.4, 2007-04, pp. : 478-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Subcortical dementia revisited: Similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA)

By Bak T.H. Crawford L.M. Hearn V. C. Mathuranath P.S. Hodges J.R

Neurocase, Vol. 11, Iss. 4, 2005-08 ,pp. : 268-273

Routledge Ltd

Access to resources Recommend Favorite

Homocysteine and brain atrophy on MRI of non-demented elderly

By den Heijer T.

Brain, Vol. 126, Iss. 1, 2003-01 ,pp. : 170-175

Oxford University Press

Access to resources Recommend Favorite

Coexistence of PSP and MSA: a case report and review of the literature

By Uchikado Hirotake DelleDonne Anthony Uitti Ryan Dickson Dennis

Acta Neuropathologica, Vol. 111, Iss. 2, 2006-02 ,pp. : 186-192

Springer Publishing Company

Access to resources Recommend Favorite

A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA)

By Armstrong R. A. Cairns N. J. Lantos P. L.

Journal of Neural Transmission, Vol. 111, Iss. 4, 2004-04 ,pp. : 485-495

Springer Publishing Company

Access to resources Recommend Favorite

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

By Molyneux P.D. Kappos L. Polman C. Pozzilli C. Barkhof F. Filippi M. Yousry T. Hahn D. Wagner K. Ghazi M. Beckmann K. Dahlke F. Losseff N. Barker G.J. Thompson A.J. Miller D.H.

Brain, Vol. 123, Iss. 11, 2000-11 ,pp. : 2256-2263

Oxford University Press

Access to resources Recommend Favorite